Article
Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI.
Neurobiology of aging - 1 Apr 2004
Berlin Daniel, Chong George, Chertkow Howard, Bergman Howard, Phillips Natalie A, Schipper Hyman M
Abstract excerpt
BACKGROUND: Pathological brain iron deposition has been implicated as a source of neurotoxic reactive oxygen species in Alzheimer disease (AD). Recent reports suggest that heterozygosity for the two common hfe mutations responsible for hereditary hemochromatosis (HH) may be a risk factor for AD, possibly by accelerating brain iron accumulation. METHODS: To test this hypothesis, we genotyped 213 sporadic AD, 106...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
